New York, NY -- (SBWIRE) -- 11/20/2017 -- Circulating Tumor Cells (CTC) Technologies Industry

Description

Wiseguyreports.Com Adds "Circulating Tumor Cells (CTC) Technologies -Market Demand, Growth, Opportunities and analysis of Top Key Player Forecast to 2021" To Its Research Database

This report on Circulating Tumor Cells (CTC) Technologies gives a market insight into technologies and services used for cancer detection. The market is analyzed by Cancer type into Prostate, Breast and Other; and by Function into Prognostics, Diagnostics and Therapy Management. The report serves as a guide to CTC industry, covering more than 190 companies that are engaged in CTC studies/screening, products and services. Major Contract Research Organizations, Research Institutes and Universities serving the CTC market are also covered in the corporate directory section of this report. Information related to recent product releases, product developments, partnerships, collaborations, and mergers and acquisitions is covered in the report. Compilation of Worldwide Patents related to CTC Technologies is also provided. A global perspective is presented along with regional analysis covering the regions of North America, Europe, and Asia-Pacific with 40 exclusive graphically represented exhibits.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/30802-circulating-tumor-cells-ctc-technologies-market-research-report

Global CTC Technologies market is predicted to increase at a CAGR of 25.91% for the analysis period 2010-2020. Cancer is a growing scourge as about 11 million people are being diagnosed with cancer every year and estimates say that are likely to be about 16 million new cases every year by 2020. Johnson & Johnson, through its Veridex LLC division, is the only company with FDA approval in the CTC Technologies area. The CellSearch's CTC test kit is valuable in assessing the prognosis of patients suffering from metastatic stage in breast cancer, prostate cancer and colorectal cancer. Several companies throughout the world have products in clinical trials and are expected to compete vigorously in the next few years with improvised products.

Report by Chapter

I. Scope and MethodologyThis chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used.

II. Report SynopsisSynopsis of the report summarizes the global Circulating Tumor Cells (CTC) Technologies market, by Cancer Type and Function Type. Global market is also analyzed by geographic regions including North America, Europe, Asia-Pacific and Rest of World. The chapter provides market values (2010 - 2020) in US$ for each geographic region. A List of major Global companies is also provided.

III. Market DynamicsMarket Dynamics chapter provides information on global markets for Circulating Tumor Cells (CTC) Technologies. The chapter includes global market analysis (in US$) by geographic region; analysis of each region by both Cancer type and Function type; a brief business profile of (59) major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches, etc. The section includes key market trends and an industry outlook.

IV. Product/Technology ResearchThis chapter gives an insight into Circulating Tumor Cells (CTC) Technologies market including definitions, segmentation and applications. The chapter also includes product trends and potential opportunities. Various CTC detection methods, and the challenges faced by the industry are also discussed. Various research activities in the field of CTC Technologies finds a mention in this chapter.

V. Corporate DirectoryThis chapter provides a global region-wise list of 150 plus companies, CROs, hospitals and academic institutions that offer Circulating Tumor Cells (CTC) Technologies products and/or services

VI. Patents InformationThis chapter provides a compilation of worldwide patents related to Circulating Tumor Cells (CTC) Technologies.

Leave a Query @ https://www.wiseguyreports.com/enquiry/30802-circulating-tumor-cells-ctc-technologies-market-research-report

Report Highlights

Global CTC Technologies market is predicted to increase at a CAGR of 25.91% for the analysis period 2010-2020. Cancer is a growing scourge as about 11 million people are being diagnosed with cancer every year and estimates say that are likely to be about 16 million new cases every year by 2020. Johnson & Johnson, through its Veridex LLC division, is the only company with FDA approval in the CTC Technologies area. The CellSearch's CTC test kit is valuable in assessing the prognosis of patients suffering from metastatic stage in breast cancer, prostate cancer and colorectal cancer. Several companies throughout the world have products in clinical trials and are expected to compete vigorously in the next few years with improvised products.

Why Buy This Report?

This report may help Strategists, Investors, Laboratories, Contract Research Organizations, Biotechnology & Healthcare Companies, Academic Professionals, Drug Approval Authorities, and Other Organizations to –

Identify Market Opportunities
Review and Analyze Global and Regional Markets
Gauge Market Potential for your Products
Identify Competition
Use Market Research for exploring new areas
Acquire Meaningful Guidelines for Strategic Planning
Gear up for Market Entry
Get Actionable Information

Analytics and data presented in each report pertain to several parameters such as –

Global and Regional Market Sizes, Market Shares, Market Trends
Product (Global and Regional) Market Sizes, Market Shares, Market Trends
Technology Trends
Corporate Intelligence
Key Companies By Sales, Brands, Products
Other Strategic Business Affecting Data
?Companies Discussed

13+ Circulating Tumor Cells (CTC) Technologies Company Insight Profiles
194+ Company Directory Listing
 Company Insight Profiles List

Abnova Corporation (Taiwan)
AVIVA BioSciences Corporation (USA)
BioCep Ltd. (Israel)
Canopus Bioscience Ltd. (Canada)
Exelixis, Inc. (USA)
Fluxion Biosciences, Inc. (USA)
Ikonisys, Inc. (USA)
Miltenyi Biotec, Inc. (USA)
On-Q-ity (USA)
RareCells SAS (France)
ScreenCell (France)
Telo VISION, LLC (USA)
Veridex, LLC (USA)

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=30802
                                                                                                
Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US)  Ph: +44 208 133 9349 (UK)